Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
$19.30 +0.25 (1.31%)
As of 02/24/2021 15:59:55 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.